Pharmacodynamics of cisatracurium in the intensive care unit: An observational study

Annals of Intensive Care

Volumn 4, Issue 1, 2014, Pages

  Dieye, Eric ^a   Minville, Vincent ^a   Asehnoune, Karim ^b   Conil, Claude ^a   Cougot, Pierre ^a   Georges, Bernard ^a   Fourcade, Olivier ^a   Conil, Jean Marie ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Cisatracurium; Current anesthetic practice; ICU; Neuromuscular monitoring

Indexed keywords

CISATRACURIUM;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL PHARMACOLOGY; CONTROLLED STUDY; CORRUGATOR SUPERCILII MUSCLE; DOSE TIME EFFECT RELATION; ELECTIVE SURGERY; FEMALE; HISTAMINE RELEASE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; OBSERVATIONAL STUDY; PARALYSIS; PERIPHERAL NERVE STIMULATOR; PHARMACODYNAMICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEATED DRUG DOSE; SIDE EFFECT; SKELETAL MUSCLE; TRACHEOSTOMY; VERY ELDERLY;

EID: 84895823690     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-4-3     Document Type: Article

References (27)

1. Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal J-M, Perez D, Seghboyan J-M, Constantin J-M, Courant P, Lefrant J-Y, Guérin C, Prat G, Morange S, Roch A, ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363:1107-1116.
2. Boyd AH, Eastwood NB, Parker CJ, Hunter JM: Pharmacodynamics of the 1R cis-1′R cis isomer of atracurium (51 W89) in health and chronic renal failure. Br J Anaesth 1995, 74:400-404.
3. De Wolf AM, Freeman JA, Scott VL, Tullock W, Smith DA, Kisor DF, Kerls S, Cook DR: Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 1996, 76:624-628.
4. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ: Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1996, 84:300-308.
5. Eastwood NB, Boyd AH, Parker CJ, Hunter JM: Pharmacokinetics of 1R-cis 1′R-cis atracurium besylate (51 W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 1995, 75:431-435.
6. Klessig HT, Geiger HJ, Murray MJ, Coursin DB: A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992, 20:1341-1345.
7. Sharpe MD: The use of muscle relaxants in the intensive care unit. Can J Anaesth 1992, 39:949-962.
8. Meistelman C, Plaud B: Neuromuscular blockade: is it still useful in the ICU? Eur J Anaesthesiol Suppl 1997, 15:53-56.
9. Sapirstein A, Hurford WE: Neuromuscular blocking agents in the management of respiratory failure. Indications and treatment guidelines. Crit Care Clin 1994, 10:831-843.
10. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, Schein RM, Spevetz A, Stone JR: Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of critical care medicine. Crit Care Med 1995, 23:1601-1605.
11. Miller RD: Use of neuromuscular blocking drugs in intensive care unit patients. Anesth Analg 1995, 81:1-2.
12. Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ: The clinical neuromuscular pharmacology of 51 W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995, 82:1139-1145.
13. Lepage JY, Malinovsky JM, Malinge M, Lechevalier T, Dupuch C, Cozian A, Pinaud M, Souron R: Pharmacodynamic dose-response and safety study of cisatracurium (51 W89) in adult surgical patients during N2O-O2-opioid anesthesia. Anesth Analg 1996, 83:823-829.
14. Bluestein LS, Stinson LW, Lennon RL, Quessy SN, Wilson RM: Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation. Can J Anaesth 1996, 43:925-931.
15. Littlejohn IH, Abhay K, Sayedel A, Broomhead CJ, Duvaldestin P, Flynn PJ: Intubating conditions following 1R CIS, 1′R CIS atracurium (51W89). A comparison with atracurium. Anaesthesia 1995, 50:499-502.
16. Beemer GH, Bjorksten AR: Pharmacodynamics of atracurium in clinical practice: effect of plasma potassium, patient demographics, and concurrent medication. Anesth Analg 1993, 76:1288-1295.
17. Waud BE, Waud DR: Interaction of calcium and potassium with neuromuscular blocking agents. Br J Anaesth 1980, 52:863-866.
18. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T: Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992, 20:304-307.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
20. Melloni C, Devivo P, Launo C, Mastronardi P, Novelli GP, Romano E: Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia. Minerva Anestesiol 2006, 72:299-308.
21. Boyd AH, Eastwood NB, Parker CJ, Hunter JM: Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51 W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996, 76:382-388.
22. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51 W89 in intensive care unit patients. Anesth Analg 1995, 81:3-12.
23. Mellinghoff H, Radbruch L, Diefenbach C, Buzello W: A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996, 83:1072-1075.
24. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM: Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992, 76:822-843.
25. Hogue CW, Ward JM, Itani MS, Martyn JA: Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. J Appl Physiol 1992, 72:1326-1331.
26. Danon MJ, Carpenter S: Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991, 14:1131-1139.
27. Ibebunjo C, Nosek MT, Itani MS, Martyn JA: Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy. J Pharmacol Exp Ther 1997, 283:443-451.